Abstract
Plasma protein therapies are either manufactured using human plasma as starting material or through the use of alternative technologies to produce recombinant plasma protein therapies. Most of the chapter is written with a focus on the plasma that is used for the manufacture of stable therapies.
Get full access to this article
View all access options for this article.